Garry Carls, M.D., M.B.A., Chairman of the Board : Garry Carls, MD., MBA, is a radiologist with expertise in the latest in digital imaging technology. He has broad experience in both the academic and private practice arenas. More ...

Tony Barnes, Ph.D., Director: Dr. Barnes is experienced in mathematical biology, pharmaceutical discovery and development, medical diagnostics and business development. He has held senior positions in development and marketing at Abbott Laboratories, Johnson and Johnson, Ciba-Chiron and Immunicon and has consulted for Merck and Bristol Myers-Squibb. More ...

Isabelle Guyon, Ph.D., VP : Dr. Guyon is the co-inventor of the SVM technique and considered a leading expert in pattern recognition and machine learning techniques. Her research includes studies on artificial neural networks, with several contributions on architecture design, learning algorithms and applications to character recognition. More...

Mary Napier, M.S., M.Phil, M.B.A., Cantab, Director
Mary Napier is a director of Business development at BIOwulf Genomics. Mary is completing her MBA at the University of Chicago and specializing in finance and strategy. Prior to the MBA program Mary was a business consultant where she drew upon her experience as a molecular biologist.More ...

Trey Rossiter, M.B.A., VP :Trey Rossiter contributes both technical and business expertise to the management of Biowulf Technologies, LLC and BIOwulf Genomics, Inc. He was directly responsible for developing the architecture and building the Company's patented BIOwulf™ parallel computing cluster. More...

Bernhard Schölkopf, Ph.D., VP: Dr. Schölkopf comes to BIOwulf Technologies from the Microsoft Research Cambridge Lab. His scientific interests are in the field of machine learning and perception. In particular, he studies support vector and kernel methods for understanding high-dimensional data. He is the co-author of several books on Support Vector learning. More...

Michael Stern, MBA, VP : More ...

Julie Williams, P.hD., Director of Scientific Affairs : More ...

Vladimir Vapnik, Ph.D., Co-Chairman, Scientific Advisory Board : Prof Vapnik, a co-inventor of the SVM technique, is considered the father of Statistical Learning Theory, the mathematical foundation of the most promising developments in Machine Learning. The company has entered into an exclusive agreement with Dr. Vapnik under which Biowulf has exclusive rights to his services and ownership of any discoveries in the fields of medicine and genomics. More...

Herb Fritsche, Ph.D.
Dr. Fritsche. is currently a professor and the Chief, Clinical Chemistry Section, Department of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center with 31 years of tenure. Dr. Fritsche is a nationally recognized figure in cancer research particularly cancer diagnostics and is a member of the BIOwulf Genomics Advisory Board. He is involved in national and international efforts in cancer control.